Crossmark

Use of Tirofiban to Prevent Ischemic Events in Patients with CYP2C19 Loss-of-Function Alleles during Flow Diversion of Intracranial Aneurysm: A Multicenter Cohort Study

Crossref DOI link: https://doi.org/10.1007/s12975-023-01171-3

Published Online: 2023-07-31

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Yangyang

Kang, Huibin

Li, Wenqiang

Luo, Bin

Wang, Chao

Xie, Ruhang

Zhu, Yongnan

Peng, Qichen

Zhang, Yisen

Liu, Jian

Zhang, Ying

Mu, Shiqing

Guan, Sheng

Feng, Wenfeng

Yang, Xinjian
Funding

Funding for this research was provided by:

National Natural Science Foundation (81671139 and 82072036)

Capital’s Funds for Health Improvement and Research (2022-1-2041)

Summit Talent Program (DFL20220503)
License Information

Text and Data Mining valid from 2023-07-31

Version of Record valid from 2023-07-31
More Information

Article History

Received: 13 February 2023

Revised: 13 February 2023

Accepted: 20 June 2023

First Online: 31 July 2023

Declarations

:

: This study involves human participants and was approved by the Ethics Committee of Beijing Tiantan Hospital (KY2022-068–02). Participants gave informed consent to participate in the study before taking part.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare that they have no conflict of interest.

: The findings and conclusions in this report are those of the author(s).

Document is current

Any future updates will be listed below